JPMorgan Chase & Co’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
|
|||||
|
2025
Q1 | $9.15M | Sell |
|
|||||
|
2024
Q4 | $9.62M | Sell |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $3.3M | Buy |
|
|||||
|
2024
Q1 | $2.56M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $2.48M | Buy |
|
|||||
|
2023
Q2 | $1.65M | Buy |
|
|||||
|
2023
Q1 | $439K | Buy |
|
|||||
|
2022
Q4 | $611K | Sell |
|
|||||
|
2022
Q3 | $745K | Sell |
|
|||||
|
2022
Q2 | $1.19M | Buy |
|
|||||
|
2022
Q1 | $1.51M | Buy |
|
|||||
|
2021
Q4 | $1.74M | Sell |
|
|||||
|
2021
Q3 | $2M | Sell |
|
|||||
|
2021
Q2 | $2.06M | Sell |
|
|||||
|
2021
Q1 | $2.85M | Sell |
|
|||||
|
2020
Q4 | $2.23M | Buy |
|
|||||
|
2020
Q3 | $142K | Buy |
|
|||||
|
2020
Q2 | $160K | Sell |
|
|||||
|
2020
Q1 | $136K | Sell |
|
|||||
|
2019
Q4 | $204K | Sell |
|
|||||
|
2019
Q3 | $968K | Buy |
|
|||||
|
2019
Q2 | $355K | Buy |
|
|||||
|
2019
Q1 | $336K | Sell |
|
|||||
|
2018
Q4 | $333K | Buy |
|
|||||
|
2018
Q3 | $536K | Buy |
|
|||||
|
2018
Q2 | $352K | Buy |
|